YELENA KAGAN, O.D.
Optometrist in BROOKLYN, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
YELENA KAGAN, O.D. reported a CMS MIPS final score of 0/100 — below the 83.1 national average — and filed 556 Medicare Part D claims in 2023.
- 0/100
- MIPS score · -83 vs avg
- 556
- Part D claims, 2023
- 51%
- generic prescribing
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
YELENA KAGAN, O.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
0 0th percentile higher than 0% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
What does the federal data show about YELENA KAGAN, O.D.?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New York
How Optometrist compares to other specialties among New York providers
Optometrist share within New York
Optometrist is one of the more visible NUCC categories in New York
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
YELENA KAGAN, O.D.'s 2023 MIPS final score plotted against the Optometrist national average
- MIPS Final Score
- 0/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Optometrist) — 0/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Optometrist US NPIs
0/100 MIPS final score — 83.1 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Optometrist. Quality dim: 0.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
YELENA KAGAN, O.D. appears in the CMS NPPES registry as a Optometrist provider holding O.D. credentials at 3723 NOSTRAND AVE, BROOKLYN, NY, 11235, with a listed phone of (718) 646-6200. NPI 1427287440 was issued on 07/12/2009. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KAGAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 556 prescription claims written by this provider, covering 162 Medicare beneficiaries and totaling roughly $174K in drug spend, split 49% brand-name and 51% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 0/100 for the 2023 performance year (Quality 0), compared with the national average of 83.1.
Optometrist is a high-volume specialty nationwide, with 60,463 enrolled providers across 56 states and an average of 257 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1427287440 |
|---|---|
| Specialty | Optometrist |
| Credentials | O.D. |
| Gender | Female |
| NPI Issued | 07/12/2009 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm YELENA KAGAN, O.D.'s current license status, disciplinary history, and board certifications with the New York State Education Department, Office of the Professions in New York before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
License & disciplinary context — New York NYSBPMC 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to YELENA KAGAN, O.D.. To verify YELENA KAGAN, O.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
49% brand-name claims vs 51% generic, on 556 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 650
- Total Day Supply
- 17,795
- Brand vs Generic
- 49% brand / 51% generic
- Brand Drug Cost
- $162K
- Generic Drug Cost
- $13K
Patient Demographics
- Average Patient Age
- 75.5 years
- Avg HCC Risk Score
- 1.41
- Gender Split
- 68% female / 32% male
- Age Distribution
- <65: 13, 65-74: 62, 75-84: 57, 85+: 30
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What YELENA KAGAN, O.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Restasis
Restasis
147 claims
- Olopatadine Hcl
Olopatadine Hcl
69 claims
- Azelastine Hcl 51
Azelastine Hcl
51 claims
- Latanoprost 35
Latanoprost
35 claims
- Ofloxacin 34
Ofloxacin
34 claims
- Zerviate 26
Zerviate
26 claims
- Neomycin-Polymyxin… 20
Neomycin-Polymyxin-Dexameth
20 claims
- Tobramycin-Dexamet… 19
Tobramycin-Dexamethasone
19 claims
| Drug | Claims |
|---|---|
| Restasis Cyclosporine | 147 |
| Olopatadine Hcl | 69 |
| Azelastine Hcl | 51 |
| Latanoprost | 35 |
| Ofloxacin | 34 |
| Zerviate Cetirizine Hcl | 26 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 20 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 19 |
| Lumigan Bimatoprost | 18 |
| Xiidra Lifitegrast | 18 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Optometrist Overview
How YELENA KAGAN, O.D. fits within the Optometrist landscape nationally.
YELENA KAGAN, O.D.'s 556 claims are above the specialty average of 257.
Nearby Optometrist Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as KAGAN.
Compare Optometrist nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New York
Frequently Asked Questions
What is YELENA KAGAN, O.D.'s specialty? ▼
How much does YELENA KAGAN, O.D. prescribe under Medicare Part D? ▼
What is YELENA KAGAN, O.D.'s Medicare quality score? ▼
Where is YELENA KAGAN, O.D. located? ▼
What is YELENA KAGAN, O.D.'s NPI number? ▼
Does YELENA KAGAN, O.D. prescribe more brand-name or generic drugs? ▼
How many Optometrist providers are there in the US? ▼
What drugs does YELENA KAGAN, O.D. prescribe most often? ▼
Does YELENA KAGAN, O.D. accept Medicare? ▼
How can I verify YELENA KAGAN, O.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology